Back
Zevra Therapeutics Stock Predictions
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
21
ZVRA
Zevra Therapeutics
Last Price:
$6.98
Seasonality Move:
-7.47%
7 Day Trial
ALL ACCESS PASS
$
7
He's already IPO'd once - this time's different
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Zevra Therapeutics Stock Forecast
-
Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 7.8% based on the past 10 years of stock performance.
-
Zevra Therapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Zevra Therapeutics Stock Undervalued?The current Zevra Therapeutics [ZVRA] share price is $6.90. The Score for ZVRA is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
ZVRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Zevra Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Zevra Therapeutics has on average historically fallen by 7.8% based on the past 10 years of stock performance.
Zevra Therapeutics Stock Rating
Sell
21
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics overpriced?
-
Zevra Therapeutics has fallen lower in 6 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Zevra Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com
52-Week Data
52-Week High:
9.76
52-Week Low:
4.20
Prediction Charts
Market Cap:
373.4M
Price in USD:
6.90
Volume:
663.4K
Beta:
1.80
Technical Analysis
SMA50:
7.72
SMA100:
8.17
SMA200:
7.64
52-Wk Change:
39.68%
Stock Predictions
-
Is Zevra Therapeutics stock public?Yes, Zevra Therapeutics is a publicly traded company.
-
What is the Zevra Therapeutics stock quote today?The Zevra Therapeutics stock price is 6.90 USD today.
-
How to buy Zevra Therapeutics stock online?You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-25 | 8.16 | 8.15 | 8.22 | 7.95 |
| Mar-26 | 8.15 | 7.85 | 8.21 | 7.78 |
| Mar-27 | 7.88 | 7.96 | 8.00 | 7.80 |
| Mar-28 | 7.99 | 7.85 | 7.99 | 7.77 |
| Mar-31 | 7.71 | 7.49 | 7.75 | 7.45 |
| Apr-1 | 7.63 | 7.32 | 7.63 | 7.26 |
| Apr-2 | 7.23 | 7.66 | 7.68 | 7.19 |
| Apr-3 | 7.38 | 7.43 | 7.53 | 7.30 |
| Apr-4 | 7.21 | 7.04 | 7.35 | 6.90 |
| Apr-7 | 6.74 | 7.05 | 7.41 | 6.63 |
| Apr-8 | 7.27 | 6.59 | 7.40 | 6.55 |
| Apr-9 | 6.44 | 6.85 | 7.02 | 6.19 |
| Apr-10 | 6.65 | 6.56 | 6.68 | 6.32 |
| Apr-11 | 6.54 | 6.90 | 6.95 | 6.52 |
Zevra Therapeutics Earnings
Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Zevra Therapeutics Forecast Revenue Growth
Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and an increase next year of $0.54 per share.
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.